Approved indications: Ophthalmic ketorolac is approved in the U.S. to reduce ocular pain and inflammation after cataract extraction and to relieve ocular itching due to seasonal allergic conjunctivitis.

Off‑label uses: Eye‑care clinicians may use ketorolac drops off label for inflammation or pain after other eye surgeries or procedures, or for other allergic or inflammatory eye conditions, generally supported by small clinical studies and clinical experience rather than large pivotal trials.

Efficacy expectations: For post‑surgical use, patients often notice reduced pain and light sensitivity within the first day, with inflammation typically improving over several days to weeks as directed by the surgeon; for allergic conjunctivitis, itching relief can begin within hours of instillation and is maintained with regular dosing.

Comparison to similar drugs: Compared with steroid eye drops, ketorolac is generally less potent for severe inflammation but avoids steroid‑specific risks like elevated eye pressure and cataract progression, and its effectiveness for mild to moderate post‑operative inflammation and allergy symptoms is comparable to other ophthalmic NSAIDs (such as diclofenac or nepafenac) when dosed appropriately.

Typical dosing and use: For post‑cataract surgery inflammation and pain, adults and children 2 years and older commonly use 1 drop in the affected eye(s) 4 times daily starting shortly before or right after surgery and continuing for about 2 weeks or as directed; for seasonal allergic conjunctivitis, the usual dose is 1 drop in the affected eye(s) 4 times daily during the symptomatic period.

How to apply: Wash hands, tilt the head back, pull down the lower eyelid to form a small pocket, instill one drop without touching the tip to the eye, then close the eye gently for 1–2 minutes; if using other eye drops, separate administration by at least 5 minutes, and apply ointments last.

Special instructions: Do not wear contact lenses while the eyes are red or inflamed unless your eye doctor specifically allows it, and remove soft contact lenses before using the drops if permitted, waiting at least 15 minutes before reinsertion.

Missed dose: If you miss a dose, apply it as soon as you remember unless it is almost time for the next dose, in which case skip the missed dose and resume the regular schedule without doubling drops.

Overdose: Accidental instillation of extra drops into the eye is unlikely to cause serious problems but may increase local irritation; if the drops are swallowed or if there are unusual or severe symptoms after excessive use, contact a poison control center or seek medical care promptly.

Common side effects: The most frequent effects are transient burning or stinging on instillation, eye redness, mild eye discomfort, blurred vision right after use, and headache; these are usually mild, short‑lived, and occur in a minority of users.

Serious or rare adverse effects: Seek immediate care for signs such as severe or persistent eye pain, sudden vision changes, marked redness or swelling, discharge suggesting infection, eye bleeding, corneal thinning or ulcer symptoms (feeling of something in the eye, worsening pain, light sensitivity), or allergic reactions including eyelid swelling, rash, or breathing difficulty.

Warnings and precautions: Use with caution in people with a history of bleeding disorders, prior corneal defects or surgeries that impair healing, dry eye or rheumatoid arthritis (which may raise corneal risk), or known NSAID or aspirin hypersensitivity; in pregnancy, especially in the third trimester, systemic NSAIDs are generally avoided, and even topical ketorolac should be used only if the potential benefit justifies the risk, while breastfeeding use should be discussed with a clinician due to limited systemic exposure but limited data.

Age considerations and organ disease: Ophthalmic ketorolac is typically used in adults and children 2 years and older; because systemic absorption is low, kidney or liver disease is less of a concern than with oral ketorolac, but caution is still advised in patients at high risk for NSAID‑related problems.

Relative safety: Compared with oral ketorolac and other systemic NSAIDs, the ophthalmic form has a lower risk of whole‑body side effects like stomach ulcers or kidney injury, but it shares class‑specific concerns about delayed corneal healing and rare corneal complications, especially with prolonged or intensive use or in compromised corneas.

Reporting and safety updates: Patients in the United States can report suspected side effects to the FDA’s MedWatch program and can check the FDA’s website for the latest safety communications about ophthalmic ketorolac and other eye medications.

Drug and product interactions: Because systemic absorption is low, interactions with most oral medicines are unlikely, but caution is advised when using other topical eye medications that can affect the cornea or healing, such as topical corticosteroids, as combined use may increase the risk of delayed healing or corneal problems; use lubricating artificial tears as needed but separate them by several minutes from ketorolac drops.

Other substances and procedures: Alcohol and most foods do not significantly interact with ophthalmic ketorolac, but heavy systemic NSAID use alongside the drops may theoretically add to bleeding risks; before eye surgery or procedures, inform your surgeon that you are using ketorolac drops so they can time use appropriately.

Precautions and contraindications: Do not use ketorolac eye drops if you have had an allergic reaction to ketorolac, aspirin, or other NSAIDs that caused asthma, hives, or severe allergic symptoms; use with caution in individuals with a history of asthma, nasal polyps, bleeding problems, or prior corneal disease or surgery, and follow the prescribed duration closely to reduce corneal risks.

Monitoring needs: Routine blood tests are not usually needed for short‑term ophthalmic use, but people on prolonged therapy or with complex eye histories may need periodic eye examinations, including checks of the cornea and intraocular pressure, as determined by their eye‑care professional.

Q: How quickly will ketorolac eye drops start to relieve my eye pain or itching?
A: Many people feel some relief of pain or itching within a few hours of starting the drops, with continued improvement over several days when used regularly as prescribed.

Q: Can I use ketorolac eye drops with my other eye medications?
A: Ketorolac is often used along with antibiotic or steroid eye drops after surgery, but you should follow your eye doctor’s schedule, separate different drops by at least 5 minutes, and tell your clinician about every eye medicine you use.

Q: Is it safe to wear contact lenses while using ketorolac ophthalmic solution?
A: Contacts are generally not recommended while your eyes are red, painful, or healing after surgery, and if your doctor allows contact lens use, you should remove them before applying the drops and wait at least 15 minutes before reinserting.

Q: How long do I need to keep using ketorolac eye drops after cataract surgery?
A: Most patients use the drops for about 2 weeks, sometimes longer if directed, but the exact duration should be determined by your eye surgeon based on how your eye is healing.

Q: What should I do if the drops burn or sting when I put them in?
A: Mild, brief stinging is common and usually improves with time, but if the burning is severe, persists, or comes with worsening pain or vision changes, stop the drops and contact your eye‑care provider promptly.

Storage: Store ketorolac ophthalmic solution at room temperature, protected from light and freezing, and keep the bottle tightly closed when not in use; do not use the drops if the solution becomes discolored, cloudy, or contains particles.

Handling: Avoid touching the dropper tip to the eye, fingers, or any surface to prevent contamination, and keep out of reach of children and pets.

Disposal: Discard the bottle after the expiration date or as instructed by your pharmacist or eye doctor; do not flush medications down the toilet or pour them into drains unless instructed, and use community medicine take‑back options when available.